Cash Burning Jaguar Health (JAGX) Becomes The Most Active On Over 70% Jump

On Monday Jaguar Health (NASDAQ: JAGX) quickly popped 66.62% right after announcing a plan to develop and manufacture Crofelemer for treating patients with inflammatory diarrhea. Even today in the premarket JAGX is trying to get over the $0.70 target. More than 4 million shares are taking a crucial part to lift up the stock over $1 so traders will flock in massively.

Just like Corbus (CRBP) the shares of JAGX are heading towards the leading place by soaring over 70% meanwhile Onconova (ONTX) barely rises 35% being in the list of the most active stocks. Perhaps, this week will have more than three healthcare stocks on that list as some cannabis stocks are pretty good in gambling. However, JAGX is the most potential for the penny loving traders who always make little fortunes silently in hours.

For less than $0.70 you may get rarely active biotech stock that has been rising due to astonishing news from its media. Once you buy JAGX, expect you are able to make 300% returns within this year as the first clinical trial of Crofelemer is right on the corner. Scientists of Jaguar are now on the front line to bring the company to a stage when burning the investors’ cash will stop at all.